Biofrontera AG (B8F):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム



Biofrontera AG is a pharmaceutical company. The company is specialized in the development of drugs and medicinal cosmetics for the treatment of skin diseases and the regenerative care of damaged skin. Biofrontera’s products include Ameluz, Belixos, and Rhodoled. Its Ameluz is Biofrontera’s first prescription drug for the treatment of actinic keratosis which combines the active ingredient 5-aminolevulinic acid (ALA) with a proprietary nanoemulsion, thereby improving the skin penetration and the chemical stability. The company’s Belixos is a cream with herbal ingredients for the basic care of inflamed, itchy and flaky skin, such as in localized itching, atopic dermatitis or psoriasis. Biofrontera is headquartered in Levetkusen, Germany.

Biofrontera AG Key Recent Developments

Oct 14, 2013: Patient recruitment started in phase III study for field-therapy of actinic keratosis
Aug 23, 2013: Biofrontera reports half-year financial results for 2013
Jun 03, 2013: Biofrontera Appoints Thomas Schaffer As New CFO

This comprehensive SWOT profile of Biofrontera AG provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Biofrontera AG including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Biofrontera AG – Key Information
Biofrontera AG – Overview
Biofrontera AG – Key Employees
Biofrontera AG – Key Employee Biographies
Biofrontera AG – Key Operational Heads
Biofrontera AG – Major Products and Services
Biofrontera AG – History
Biofrontera AG – Company Statement
Biofrontera AG – Locations And Subsidiaries
Biofrontera AG – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Biofrontera AG – Business Description
Biofrontera AG – Corporate Strategy
Biofrontera AG – SWOT Analysis
SWOT Analysis – Overview
Biofrontera AG – Strengths
Biofrontera AG – Weaknesses
Biofrontera AG – Opportunities
Biofrontera AG – Threats
Biofrontera AG – Key Competitors

Section 3 – Company Financial Performance Charts

Biofrontera AG – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Biofrontera AG, Key Information
Biofrontera AG, Key Ratios
Biofrontera AG, Share Data
Biofrontera AG, Major Products and Services
Biofrontera AG, History
Biofrontera AG, Key Employees
Biofrontera AG, Key Employee Biographies
Biofrontera AG, Key Operational Heads
Biofrontera AG, Other Locations
Biofrontera AG, Subsidiaries
Biofrontera AG, Key Manufacturing facilities
Biofrontera AG, Key Competitors
Biofrontera AG, SWOT Analysis
Biofrontera AG, Ratios based on current share price
Biofrontera AG, Annual Ratios
Biofrontera AG, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Biofrontera AG, Performance Chart
Biofrontera AG, Ratio Charts


★リサーチレポート[ Biofrontera AG (B8F):企業概要、財務及び戦略的SWOT分析(Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。